In a Q&A interview with Pharmaphorum, Zulf talks about the history of Masters and how and why the company was formed. From discussing the various opportunities that present themselves to pharma companies like Masters Specialty Pharma when operating in emerging markets, to detailing some of the main challenges we have faced in this industry and how the company uses different strategies for different kinds of diseases.

“…lack of awareness, education and financial means can deter patients and their healthcare providers from seeking or accessing first world treatment regimes. Emerging markets often lack access to the relevant information needed to educate patients and their families. Advocacy groups are also rare or exist only in one city in the country and few inhabitants have heard of them.”

To read the full article, go to

Related articles